ICON plc (ICLR) PT Raised to $154 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
ICON plc (ICLR) Buys MolecularMD Corporation
February 21, 2019 10:03 AM ESTMolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in oncology, announced today that it has been acquired by ICON plc (NASDAQ: ICLR). MolecularMDs extensive scientific and clinical biomarker experience expands ICONs capabilities in molecular diagnostic testing and also adds expanded testing platforms, including next-generation sequencing and immunohistochemistry, to ICONs laboratory service offering. MolecularMDs specialty central laboratory offering and associated client base extends ICONs reach into the support of precision... More
ICON plc (ICLR) Tops Q4 EPS by 3c, Reaffirms Guidance
February 20, 2019 4:32 PM ESTICON plc (NASDAQ: ICLR) reported Q4 EPS of $1.63, $0.03 better than the analyst estimate of $1.60. Revenue for the quarter came in at $679 million versus the consensus estimate of $675.88 million.
2019 outlook reaffirmed with revenue guidance in the range of $2,735 - $2,835 million and earnings per... More